News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
283,360 Results
Type
Article (15400)
Company Profile (283)
Press Release (267677)
Multimedia
Podcasts (50)
Webinars (7)
Section
Business (83392)
Career Advice (160)
Deals (13808)
Drug Delivery (39)
Drug Development (51447)
Employer Resources (32)
FDA (6141)
Job Trends (5487)
News (150485)
Policy (10583)
Tag
Academia (991)
Accelerated approval (2)
Adcomms (12)
Allergies (54)
Alliances (22914)
ALS (67)
Alzheimer's disease (860)
Antibody-drug conjugate (ADC) (103)
Approvals (6167)
Artificial intelligence (128)
Autoimmune disease (18)
Automation (5)
Bankruptcy (109)
Best Places to Work (4854)
BIOSECURE Act (7)
Biosimilars (44)
Biotechnology (233)
Bladder cancer (59)
Brain cancer (20)
Breast cancer (159)
Cancer (1507)
Cardiovascular disease (122)
Career advice (141)
Career pathing (2)
CAR-T (119)
Cell therapy (336)
Cervical cancer (8)
Clinical research (41886)
Collaboration (561)
Compensation (274)
Complete response letters (14)
COVID-19 (1078)
CRISPR (42)
C-suite (167)
Cystic fibrosis (79)
Data (1560)
Denatured (11)
Depression (33)
Diabetes (139)
Diagnostics (1471)
Digital health (3)
Diversity (2)
Diversity, equity & inclusion (9)
Drug discovery (87)
Drug pricing (30)
Drug shortages (5)
Duchenne muscular dystrophy (90)
Earnings (31139)
Editorial (18)
Employer branding (5)
Employer resources (30)
Events (50801)
Executive appointments (473)
FDA (6867)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (510)
Gene editing (97)
Generative AI (10)
Gene therapy (256)
GLP-1 (376)
Government (1156)
Grass and pollen (2)
Guidances (29)
Healthcare (7076)
Huntington's disease (22)
IgA nephropathy (26)
Immunology and inflammation (92)
Indications (20)
Infectious disease (1145)
Inflammatory bowel disease (116)
Inflation Reduction Act (8)
Influenza (19)
Intellectual property (67)
Interviews (17)
IPO (7497)
IRA (11)
Job creations (921)
Job search strategy (135)
Kidney cancer (8)
Labor market (5)
Layoffs (218)
Leadership (3)
Legal (1514)
Liver cancer (36)
Lung cancer (209)
Lymphoma (102)
Machine learning (3)
Management (7)
Manufacturing (143)
MASH (54)
Medical device (3214)
Medtech (3215)
Mergers & acquisitions (6650)
Metabolic disorders (395)
Multiple sclerosis (53)
NASH (13)
Neurodegenerative disease (69)
Neuropsychiatric disorders (26)
Neuroscience (1280)
NextGen: Class of 2025 (2237)
Non-profit (961)
Now hiring (21)
Obesity (198)
Opinion (107)
Ovarian cancer (63)
Pain (48)
Pancreatic cancer (56)
Parkinson's disease (122)
Partnered (8)
Patents (132)
Patient recruitment (80)
Peanut (36)
People (26695)
Pharmaceutical (47)
Pharmacy benefit managers (5)
Phase I (14711)
Phase II (19450)
Phase III (12406)
Pipeline (839)
Policy (47)
Postmarket research (881)
Preclinical (6233)
Press Release (30)
Prostate cancer (63)
Psychedelics (35)
Radiopharmaceuticals (219)
Rare diseases (301)
Real estate (1534)
Recruiting (12)
Regulatory (9029)
Reports (15)
Research institute (997)
Resumes & cover letters (17)
Rett syndrome (4)
RNA editing (5)
RSV (10)
Schizophrenia (61)
Series A (101)
Series B (63)
Service/supplier (2)
Sickle cell disease (40)
Special edition (11)
Spinal muscular atrophy (128)
Sponsored (13)
Startups (2020)
State (1)
Stomach cancer (4)
Supply chain (24)
Tariffs (9)
The Weekly (38)
Vaccines (226)
Venture capitalists (32)
Weight loss (114)
Women's health (16)
Worklife (2)
Date
Last 7 days (531)
Last 30 days (1437)
Last 365 days (19970)
2025 (6524)
2024 (21184)
2023 (23276)
2022 (28086)
2021 (29146)
2020 (24767)
2019 (17781)
2018 (12922)
2017 (14622)
2016 (12617)
2015 (15161)
2014 (10932)
2013 (7985)
2012 (8056)
2011 (8172)
2010 (7826)
Location
Africa (160)
Alabama (42)
Alaska (2)
Arizona (55)
Arkansas (5)
Asia (17909)
Australia (3053)
California (3997)
Canada (1165)
China (369)
Colorado (151)
Connecticut (160)
Delaware (103)
Europe (39019)
Florida (492)
Georgia (129)
Idaho (20)
Illinois (245)
India (10)
Indiana (97)
Iowa (11)
Japan (77)
Kansas (63)
Kentucky (5)
Louisiana (3)
Maine (12)
Maryland (490)
Massachusetts (3144)
Michigan (73)
Minnesota (151)
Mississippi (1)
Missouri (29)
Montana (14)
Nebraska (5)
Nevada (22)
New Hampshire (16)
New Jersey (998)
New Mexico (13)
New York (1074)
North Carolina (564)
North Dakota (6)
Northern California (1764)
Ohio (118)
Oklahoma (9)
Oregon (23)
Pennsylvania (753)
Puerto Rico (6)
Rhode Island (20)
South America (224)
South Carolina (4)
South Dakota (1)
Southern California (1535)
Tennessee (26)
Texas (456)
United States (13677)
Utah (54)
Virginia (83)
Washington D.C. (32)
Washington State (359)
Wisconsin (18)
283,360 Results for "io therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
IO Biotech Presents New Data at AACR 2025 Supporting Dual Mechanism and Immune Activation of Cancer Vaccines IO102-IO103 and IO170
April 25, 2025
·
4 min read
Press Releases
IO Biotech Announces Publication of Preclinical Data Investigating Immune-Modulatory Effects of IO112, an Arginase 1-Targeting Therapeutic Cancer Vaccine Candidate
February 4, 2025
·
4 min read
Press Releases
IO Biotech Announces New Preclinical Data for Additional Pipeline Candidate Presented at the AACR-IO Conference
February 24, 2025
·
4 min read
Press Releases
IO Biotech Reports 2024 Business Highlights
March 5, 2025
·
11 min read
Press Releases
IO Biotech Completes Enrollment in Phase 2 Trial of its Investigational, Off-the-shelf Therapeutic Cancer Vaccine, IO102-IO103, as Neoadjuvant/Adjuvant Treatment for Patients with Resectable Melanoma or Head and Neck Cancer
January 9, 2025
·
7 min read
Press Releases
IO Biotech Showcases Scientific Leadership Through Cancer Vaccines Educational Session at the American Association for Cancer Research (AACR) Annual Meeting 2025
April 28, 2025
·
3 min read
Press Releases
MiNK Therapeutics to Present Updated Data from Phase 2 Study Testing AgenT-797 in Gastric Cancer at AACR IO Annual Meeting
February 13, 2025
·
3 min read
Press Releases
MiNK Therapeutics Presents First-in-Kind Allo-iNKTs Combination Data in 2L Gastric Cancer at AACR IO Annual Meeting
February 24, 2025
·
6 min read
Press Releases
IO Biotech Announces Acceptance of Abstracts to be Presented at the 2025 American Association for Cancer Research (AACR) Annual Meeting
March 25, 2025
·
5 min read
Press Releases
Akoya Biosciences Expands Biopharma Service Portfolio with New ADC Breast Cancer Assay and Real-world IO60 Insights at AACR 2025
April 24, 2025
·
5 min read
1 of 28,336
Next
